Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03150056
Title Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Molibresib

Enzalutamide + Molibresib

Prednisone

Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.